Announcements Trials
Browse Landscape

Status

Unknown 5Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 7NETWORK 2NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Ototoxicity 1Central Nervous System Neoplasms 1

Interventions

Specimen Handling 188Magnetic Resonance Spectroscopy 143Biopsy 116Nivolumab 39X-Rays 29Immunoglobulin G 29Disulfides 29Radiation 28Carboplatin 27atezolizumab 25Taxes 25Paclitaxel 25pembrolizumab 23Radiotherapy 23Ipilimumab 23CTLA-4 Antigen 23olaparib 22Cyclophosphamide 22Cisplatin 21Platinum 20Gemcitabine 20Doxorubicin 20Bevacizumab 201,2-diaminocyclohexaneplatinum II citrate 20Phantoms, Imaging 19Vincristine 17trametinib 16cabozantinib 15Rituximab 15ibrutinib 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × NIH × Mental Status and Dementia Tests × Clear all
NCT00683319 2013-09-20

Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy

National Cancer Institute (NCI)

Active not recruiting
50 enrolled
CNS

Ototoxicity, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡